The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

PHASE2CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

June 11, 2019

Study Completion Date

July 28, 2019

Conditions
Coronary Artery DiseasePercutaneous Coronary InterventionPlatelet Aggregation Inhibitors
Interventions
DRUG

Vicagrel 5mg

Experimental group 1 : Vicagrel 20mg loading followed by 5mg/day for 28 days

DRUG

Vicagrel 6mg

Experimental group 2 : Vicagrel 24mg loading followed by 6mg/day for 28 days

DRUG

Vicagrel 7.5mg

Experimental group 3 : Vicagrel 30mg loading followed by 7.5mg/day for 28 days

DRUG

Clopidogrel 75mg

Control group : Clopidogrel 300mg loading followed by 75mg/day for 28 days

Trial Locations (27)

100029

Beijing Anzhen Hospital, Capital Medical Universily, Beijing

China-Japan Friendship Hospital, Beijing

100032

Peking Union Medical College Hospital, Beijing

110015

the General Hospital of Shenyang Military Region of The Chinese People's Liberation Army(The General Hospital of Shenyang Military), Shenyang

The People's Hospital of Liaoning Province, Shenyang

110134

Shengjing Hospital of China Medical University, Shenyang

130021

First Hospital of Jilin University, Changchun

130041

Second Hospital of Jilin University, Changchun

210008

Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing

210009

Zhongda Hospital of Southeast University, Nanjing

233004

First Affiliated Hospital Bengbu Medical College, Bengbu

300052

Tianjin Medical University General Hospital, Tianjing

300121

Tianjin People's Hospital, Tianjin

310009

Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

310020

Sir Run Run Shaw Hospital, Hangzhou

330006

Jiangxi Provincial People's Hospital, Nanchang

410004

Changsha Central Hospital, Changsha

410008

Xiangya Hospital of Central South University, Changsha

410011

Second Xiangya Hospital of Central South University, Changsha

410013

Third Xiangya Hospital of Central South University, Changsha

430022

Wuhan Asia Heart Hospital, Wuhan

510030

Guangdong General Hospital, Guangzhou

510080

First Affiliated Hospital of Zhongshan University, Guangzhou

646000

Affiliated Hospital of Southwest Medical University, Luzhou

810007

Qinghai Provincial People's Hospital, Xining

050100

First Hospital of Hebei Medical University, Shijiazhuang

044000

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT03599284 - The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel | Biotech Hunter | Biotech Hunter